Skip to main content
Clinical Trials/NL-OMON46960
NL-OMON46960
Completed
Not Applicable

A Feasibility Study to Assess Safety and Efficacy of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Stenosis (AS) (CA-0001)/ Symptomatic Severe Aortic Regurgitation (AR) (CA-0002) - JenaValve AS/AR Feasibility Study

JenaValve Technology, Inc.0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
leaking heart valve
Sponsor
JenaValve Technology, Inc.
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients with symptomatic severe aortic stenosis or symptomatic severe aortic regurgitation who are at high risk for surgical aortic valve replacement

Exclusion Criteria

  • Congenital uni\- or bicuspid aortic valve morphology, previous prosthetic aortic valve implant, mitral regurgitation greater than moderate

Outcomes

Primary Outcomes

Not specified

Similar Trials